Mounjaro®
Starting from £179.99/mo
Start journey Learn moreGallstones are a known risk during rapid weight loss, and Mounjaro is no exception. The good news is that the steps most likely to reduce that risk are straightforward: lose weight steadily rather than sharply, keep eating a little fat at every meal, and stay well hydrated. Read on for the reasoning behind each of those, and what to watch for. Mounjaro (tirzepatide) is a prescription-only medicine, so any adjustments to how you use it should always go through your prescriber first — not the Patient Information Leaflet alone.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
When the body breaks down fat stores quickly, the liver releases more cholesterol into bile than the gallbladder can easily dissolve. That concentrated bile is where stones begin. This is not unique to Mounjaro (any route to rapid weight loss carries the same risk) but it is worth knowing because understanding the mechanism tells you exactly which levers to pull.
Tirzepatide slows gastric emptying and reduces appetite markedly, which means many people eat significantly less, especially in the early months of treatment. If meals become very small or fat is cut out entirely in an attempt to ease nausea, the gallbladder may go hours without contracting. Stagnant bile thickens. That is the specific pattern most associated with gallstone formation in people using GLP-1 medicines, as the NHS tirzepatide patient information acknowledges by listing gallbladder problems among the known side effects to watch for.
Knowing the mechanism also explains why the prevention steps below are not arbitrary dietary advice, each one directly interrupts the bile-stagnation cycle. Your prescriber can tell you whether your personal history (previous gallstones, a family history, or a very high starting BMI) puts you at higher baseline risk before you begin treatment, and reading the dedicated guidance on taking Mounjaro with gallstones is a sensible way to prepare for that conversation. Exploring the broader relationship between Mounjaro and gallstones is a useful starting point if this is a concern you want to understand fully.
The single most effective dietary step is also the one people on GLP-1 medicines most often accidentally skip: include a small amount of fat in every meal you eat, even when your appetite is very low. Fat is the strongest stimulus for cholecystokinin release, the hormone that tells your gallbladder to squeeze and empty. Without that signal, bile pools.
You do not need large portions. A drizzle of olive oil, a few slices of avocado, a small handful of nuts, a piece of salmon, any of these gives the gallbladder enough reason to contract. The problem arises when people reduce portions so drastically that they stop including fat-containing foods altogether, or when nausea leads to an all-plain-crackers diet for days at a stretch.
If nausea is the barrier, that is a conversation for your prescriber rather than a reason to cut fat entirely. Dose timing, meal timing, and anti-nausea strategies are all worth discussing. For practical context on avoiding gallstones specifically during tirzepatide treatment, our clinical team has written in more detail about dietary adjustments that fit real eating patterns. This is also worth reading alongside guidance on preventing muscle loss on Mounjaro, since the protein-adequate eating that protects muscle tends to include enough fat to keep the gallbladder active too.
Slow, steady weight loss is kinder to the gallbladder than a sharp early drop. Clinically, losing more than about 1–1.5 kg per week is associated with a meaningful increase in gallstone risk. Tirzepatide's dose-escalation schedule (starting at 2.5 mg and stepping up gradually) is partly designed to avoid exactly this kind of sharp early loss, but appetite suppression can still be intense in some people, particularly at the beginning.
If the scales are moving faster than expected in your first few months, mention it at your next prescriber review. It is not a problem to celebrate and ignore. The prescriber may advise a slower titration or specific dietary adjustments to moderate the pace. Some people find the appetite suppression on a Monday and Tuesday after an injection day is so strong that they barely eat, keeping a rough log of what you're actually consuming makes these conversations much easier.
Hydration matters separately. Bile becomes more concentrated when you are even mildly dehydrated, and GI side effects (nausea, vomiting, reduced thirst) make dehydration easy to slide into on tirzepatide. Aiming for six to eight glasses of water across the day is a reasonable baseline, though your prescriber or a dietitian can give you a more personalised target. Keeping water at the desk, rather than only remembering it before bed, tends to work better in practice. For a fuller overview of how tirzepatide works and what to expect, the tirzepatide treatment guide covers the mechanism in plain terms.
Prevention is the aim, but recognising a problem early matters just as much. Gallstones do not always cause pain; many sit quietly for years. When they do cause symptoms, the classic pattern is a sudden, cramping pain under the right ribs or in the upper-middle abdomen, often starting thirty to sixty minutes after eating, particularly a fatty meal. The pain may radiate to the right shoulder or through to the back. It can last anywhere from twenty minutes to several hours.
If that pain is severe, or if it is accompanied by a fever, yellowing of the skin or eyes, dark urine, or pale stools, those signs suggest the stone has moved to block a duct. That is a medical emergency: go to A&E or call 999. Do not wait for your next scheduled check-in, and do not take another dose of Mounjaro until you have spoken to a clinician. The MHRA's January 2026 Drug Safety Update on GLP-1 medicines specifically highlighted acute pancreatitis as a serious risk to monitor, its symptoms can overlap with severe gallbladder pain, which is another reason to get assessed promptly rather than managing it at home.
People who have had gallstones before starting Mounjaro should make sure their prescriber knows. There is dedicated guidance on whether Mounjaro is appropriate if you already have gallstones, it is a question our prescribers assess individually rather than applying a blanket rule. And if you are weighing up treatment options more broadly, the weight-loss treatment overview sets out how different medicines compare so you can go into a consultation well prepared.
If any of this raises questions about your own situation, the right next step is a conversation with a clinician rather than trying to piece together an answer from multiple sources. At nume, a GPhC-registered prescriber reads every consultation personally (not software) on the same day it is submitted. You can start your free consultation here if you'd like clinical guidance specific to you.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.